Advanced Search
Contact | Corporate | Help

A Trial of Taxol and Bevacizumab vs. Gemcitabine, Taxol, and Bevacizumab in Advanced Breast Cancer

Sponsors:
  • Eli Lilly and Company
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Breast Cancer
  • Cancer of Breast
  • Cancer of the Breast
  • Breast Neoplasms
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: gemcitabine
  • Drug: paclitaxel
  • Drug: bevacizumab
Enrollment:
187

Additional information about NCT00320541.


SourceSolution © 2008-2012